Advertisement

Pharmacy World and Science

, Volume 27, Issue 6, pp 417–420 | Cite as

Gastroesophageal Reflux Disease: Clinical Features*

  • Michael PettitEmail author
Commentary

Abstract

Gastroesophageal reflux disease (GERD) is a chronic disease affecting up to 40% of people in the Western world. Risk factors associated with GERD include age and lifestyle habits, although the clinically relevant contribution of many of these factors is unclear. In GERD, refluxed gastric acid damages the oesophageal mucosa, generally when the pH falls below 4. GERD patients present a variety of symptoms, most commonly heartburn and regurgitation. Oesophageal complications associated with GERD include erosions, ulcers, peptic strictures, and Barrett’s oesophagus which is implicated in the development of oesophageal adenocarcinoma. Diagnosis of GERD is problematic due to the range of symptoms which may be presented to the physician and symptom severity is frequently unrelated to disease severity. While endoscopic monitoring may be used to assess the presence and severity of GERD, a lack of visible damage does not necessarily indicate an absence of GERD. Techniques used to diagnose GERD include addition of an acid solution into the oesophagus in order to replicate symptoms (Bernstein test) or 24-hour intra-oesophageal pH monitoring. Proton pump inhibitors are effective in the treatment of GERD, acting to reduce the acidity of the gastric juice and hence reduce oesophageal damage and symptoms associated with GERD. Symptoms most indicative of GERD are those associated with erosive oesophagitis, including heartburn and acid regurgitation. Less common GERD-associated symptoms include chest pain, a range of ear, nose and throat conditions, and asthma. In contrast to perceptions of the disease as ‘merely’ heartburn, the impact on patients’ quality of life can be profound. Increasing awareness of GERD by health care professionals has led to improved diagnosis and a greater appreciation of the need for maintenance therapy.

Keywords

GERD Heartburn Oesophagus Regurgitation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heading, RC 1989Epidemiology of oesophageal reflux diseaseScand J Gastroenterol Suppl168337PubMedGoogle Scholar
  2. 2.
    Spechler, SJ 1992Epidemiology and natural history of gastro-oesophageal reflux diseaseDigestion51249PubMedGoogle Scholar
  3. 3.
    Dent, J, Holloway, RH, Toouli, J, Dodds, WJ 1988Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal refluxGut2910208PubMedGoogle Scholar
  4. 4.
    Hunt, RH 1995The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux diseaseAliment Pharmacol Ther937PubMedGoogle Scholar
  5. 5.
    Huang, JQ, Hunt, RH 1999pH, healing rate, and symptom relief in patients with GERDYale J Biol Med7218194PubMedGoogle Scholar
  6. 6.
    Hirschowitz, BI 1996Management of refractory and complicated reflux esophagitisYale J Biol Med6927181PubMedGoogle Scholar
  7. 7.
    Spechler, SJ, Goyal, RK 1986Barrett’s esophagusN Engl J Med31536271PubMedCrossRefGoogle Scholar
  8. 8.
    Blot, WJ, Devesa, SS, Kneller, R, Fraumeni, JF,Jr 1991Rising incidence of adenocarcinoma of the esophagus and gastric cardiaJ Am Med Assoc26512879CrossRefGoogle Scholar
  9. 9.
    Lagergren, J, Bergstrom, R, Lindgren, A, Nyren, O 1999Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinomaN Engl J Med34082531CrossRefPubMedGoogle Scholar
  10. 10.
    DeVault, KR, Castell, DO 1999Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The practice parameters committee of the American College of GastroenterologyAm J Gastroenterol94143442CrossRefPubMedGoogle Scholar
  11. 11.
    Lundell, L, Miettinen, P, Myrvold, HE, Pedersen, SA, Thor, K, Andersson, A 1999A randomised comparison between omeprazole and open anti-reflux surgery in the management of chronic gastro-oesophageal reflux disease: report on 5 year follow upGut45A40Google Scholar
  12. 12.
    DeVault, KR, Castell, DO 1994Current diagnosis and treatment of gastroesophageal reflux diseaseMayo Clin Proc6986776PubMedGoogle Scholar
  13. 13.
    Thomson, AB, Chiba, N, Armstrong, D, Tougas, G, Hunt, RH 1998The second Canadian gastroesophageal reflux disease consensus: moving forward to new conceptsCan J Gastroenterol125516PubMedGoogle Scholar
  14. 14.
    Bernstein, LM, Baker, LA 1958A clinical test for esophagitisGastroenterology3476081PubMedGoogle Scholar
  15. 15.
    Wu, WC 1990Ancillary tests in the diagnosis of gastroesophageal␣reflux diseaseGastroenterol Clin North Am1967182PubMedGoogle Scholar
  16. 16.
    Lundell, LR, Dent, J, Bennett, JR, Blum, AL, Armstrong, D, Galmiche, JP,  et al. 1999Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut4517280PubMedCrossRefGoogle Scholar
  17. 17.
    Fass, R 2000Empirical trials in treatment of gastroesophageal reflux diseaseDig Dis18206CrossRefPubMedGoogle Scholar
  18. 18.
    Juul-Hansen, P, Rydning, A, Jacobsen, CD, Hansen, T 2001High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patientsScand J Gastroenterol3680610CrossRefPubMedGoogle Scholar
  19. 19.
    Johnsson, F, Hatlebakk, JG, Klintenberg, AC, Roman, J, Toth, E, Stubberod, A,  et al. 2003One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux diseaseScand J Gastroenterol383549PubMedGoogle Scholar
  20. 20.
    Bardhan, KD, Muller-Lissner, S, Bigard, MA, Porro, GB, Ponce, J, Hosie, J,  et al. 1999Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidineBr Med J3185027Google Scholar
  21. 21.
    Klinkenberg-Knol, EC, Festen, HP, Meuwissen, SG 1995Pharmacological management of gastro-oesophageal reflux diseaseDrugs49695710PubMedCrossRefGoogle Scholar
  22. 22.
    Chiba, N 1997Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overviewCan J Gastroenterol1166B73BPubMedGoogle Scholar
  23. 23.
    Richter, JE 2000Extraesophageal presentations of gastroesophageal reflux disease: an overviewAm J Gastroenterol95S13PubMedGoogle Scholar
  24. 24.
    Klauser, AG, Schindlbeck, NE, Muller-Lissner, SA 1990Symptoms in gastro-oesophageal reflux diseaseLancet3352058CrossRefPubMedGoogle Scholar
  25. 25.
    Davies, HA, Jones, DB, Rhodes, J, Newcombe, RG 1985Angina-like esophageal pain: differentiation from cardiac pain by historyJ␣Clin Gastroenterol747781PubMedGoogle Scholar
  26. 26.
    Wong, RK, Hanson, DG, Waring, PJ, Shaw, G 2000ENT manifestations of gastroesophageal refluxAm J Gastroenterol95S1522PubMedGoogle Scholar
  27. 27.
    Wu, DN, Tanifuji, Y, Kobayashi, H, Yamauchi, K, Kato, C, Suzuki, K,  et al. 2000Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bronchial asthmaChest11815536CrossRefPubMedGoogle Scholar
  28. 28.
    Jailwala, JA, Shaker, R 2000Oral and pharyngeal complications of gastroesophageal reflux disease: globus, dental erosions, and␣chronic sinusitisJ Clin Gastroenterol30S358PubMedGoogle Scholar
  29. 29.
    Huxley, EJ, Viroslav, J, Gray, WR, Pierce, AK 1978Pharyngeal aspiration in normal adults and patients with depressed consciousnessAm J Med645648CrossRefPubMedGoogle Scholar
  30. 30.
    Fennerty, MB, Castell, D, Fendrick, AM, Halpern, M, Johnson, D, Kahrilas, PJ,  et al. 1996The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, suggested disease management guidelinesArch Intern Med15647784CrossRefPubMedGoogle Scholar
  31. 31.
    Revicki, DA, Wood, M, Maton, PN, Sorensen, S 1998The impact of gastroesophageal reflux disease on health-related quality of lifeAm J Med1042528CrossRefPubMedGoogle Scholar
  32. 32.
    Wiklund, IK, Junghard, O, Grace, E, Talley, NJ, Kamm, M, Veldhuyzen van Zanten, S,  et al. 1998Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)Eur J Surg Suppl583419PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Clinical Pharmacy Unit, Royal Sussex County HospitalUniversity of BrightonBrightonUK

Personalised recommendations